logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Godrej Consumer Q4 FY26: Profit Up 9.7%, Stock Falls 6%

GODREJCP

Godrej Consumer Products Ltd

GODREJCP

Ask AI

Ask AI

Stock reaction: results beat, price still slipped

Godrej Consumer Products (GCPL) shares fell sharply on Thursday even after the company reported year-on-year growth in profit and revenue for Q4 FY26. The stock slipped 5.5% to an intraday low of Rs 1,035 on the BSE, and was described as down nearly 6% during the session. The decline came despite steady volume growth across the portfolio and management commentary pointing to improving trends in key overseas markets such as Indonesia. Brokerages broadly retained constructive views, but pointed to near-term input cost pressures and category-specific demand risks.

Q4 FY26 financials: profit rises, margins steady

GCPL reported a 9.7% YoY increase in consolidated net profit for Q4 FY26 to INR 452 crore. Revenue rose 11% YoY to INR 3,900 crore from INR 3,514 crore a year earlier, indicating double-digit top-line growth in the quarter. EBITDA increased 11% YoY to INR 841.4 crore from INR 759.2 crore. EBITDA margin was unchanged at 21.6%, suggesting operating leverage was offset by costs and investment choices.

Volumes: India leads, consolidated growth stays healthy

Consolidated sales in Q4 FY26 grew 11% YoY, supported by underlying volume growth of 6%. The standalone business delivered volume growth of 8%, with sales rising 10% over the same period. Management commentary referenced weaker growth over the past two years, linked to stepped-up investments to ignite growth and expand into new categories. The company also indicated that parts of the portfolio have started to outstrip growth due to investments and profitability due to scale benefits.

International performance: Indonesia stabilises, GAUM grows

Among international markets, Indonesia sales increased 3% in Q4 FY26. Africa, the US and West Asia delivered 20% growth during the quarter, highlighting the importance of the company’s diversified geographic mix. In management commentary, the company said Indonesia delivered 4% underlying volume growth and 3% sales growth, and it expects operating conditions to improve from FY 2027 as the market normalises. It also said Africa, USA and Middle East delivered 20% top-line growth, while EBITDA grew 2% due to a deliberate increase in media spends.

Full-year FY26: steady growth with volume support

For the full FY26, consolidated sales rose 9% YoY, driven by 6% volume growth. Standalone sales grew 8% with volume growth of 6%. These figures indicate that volume remained a key driver of growth across the year, while pricing and mix supported topline expansion. The company also referred to calibrated growth at “normative EBITDA margins” for India, supported by improving demand trends and innovation.

Brokerages: positive stance, but watch input costs

Morgan Stanley maintained an Equal-weight rating with a target price of Rs 1,159, implying a 6% upside from current levels as cited in the report. It expects stronger pricing-led topline growth in Q1 and Q2 FY27, while warning that margins could remain under pressure. The brokerage noted that GCPL implemented price hikes across soaps, detergents and home insecticides in April. It also highlighted management guidance for FY27 EBITDA margins in the 24-26% band, while flagging crude oil and palm oil inflation as near-term risks.

Motilal Oswal maintained a ‘Buy’ rating with a target price of Rs 1,300, implying a potential upside of 19%. The brokerage said management remains focused on improving domestic business volumes and driving efficiencies across the value chain. It expects the GAUM business to deliver better profitability growth and sees Indonesia recovery becoming more meaningful from FY27 as market conditions stabilise. Management also expressed confidence in sustaining profitability momentum in FY27 despite macroeconomic challenges.

Near-term operating variables: commodity pressure and seasonality

Management commentary indicated that EBITDA percentage margin could see pressure in the current and next quarter, with a potential dip over three to four months. The company also pointed to category-level differences: a warmer summer could support soaps demand, but may negatively impact home insecticides. It also referenced crude sensitivity for laundry, indicating that input-cost inflation can affect profitability and near-term margins.

Board meeting and dividend watch

A board meeting was scheduled for May 6, 2026 to review audited financial results for the quarter and financial year ended March 31, 2026. Separately, analyst notes also referenced an interim dividend decision as a potential support for the stock’s outlook. The company’s calendar events are likely to remain in focus given the market’s sensitivity to guidance, margins and capital allocation signals.

Stock context: recent returns and key price levels

The stock has shown mixed performance across timeframes, with shorter-term gains but declines over longer recent periods. It has also been reported that from the beginning of the year, the shares have declined 18%. The 52-week high was cited at Rs 1,309.70 on September 4, 2025 and the 52-week low at Rs 967.05 on April 2, 2026. Market capitalisation was cited at INR 1,04,000 crore.

MetricValue
Q4 FY26 net profitINR 452 crore (YoY +9.7%)
Q4 FY26 revenueINR 3,900 crore (YoY +11%)
Q4 FY26 EBITDAINR 841.4 crore (YoY +11%)
Q4 FY26 EBITDA margin21.6% (unchanged)
Q4 FY26 underlying volume growth (consolidated)6%
Q4 FY26 standalone volume growth8%
Thursday intraday low (BSE)Rs 1,035 (down 5.5%)
Morgan Stanley targetRs 1,159 (Equal-weight)
Motilal Oswal targetRs 1,300 (Buy)
Board meetingMay 6, 2026

Godrej Consumer share price returns (as reported)

PeriodReturn
1 Day1.84%
1 Week6.15%
1 Month10.56%
3 Months-7.97%
1 Year-7.28%
3 Years13.97%
5 Years55.04%

Why the results still saw a sell-off

The session’s decline suggests investors weighed near-term risks more heavily than the reported Q4 growth. While revenue, EBITDA and profit all rose about 10-11% YoY and margins held steady, commentary highlighted near-term margin pressure tied to crude and palm oil-linked inputs. The market also appeared to factor in category-level uncertainties, including the potential summer impact on home insecticides. At the same time, brokerages staying positive indicates that the medium-term view is linked to volume momentum in India, stabilisation in Indonesia, and margin guidance for FY27.

Conclusion

GCPL’s Q4 FY26 performance showed double-digit revenue growth, stable margins and improved profitability, but the stock still fell close to 6% amid concerns around input-cost inflation and near-term margin pressure. Brokerages remained constructive, pointing to India volume growth, improving Indonesia trends and FY27 margin guidance of 24-26%. The next key marker is the May 6, 2026 board meeting to review audited results, alongside any updates on margins, pricing actions and dividend decisions.

Frequently Asked Questions

The stock slipped even after profit growth as brokerages and management commentary flagged near-term margin pressure from crude and palm oil-linked inputs and category-level demand risks.
Net profit rose 9.7% YoY to INR 452 crore, revenue increased 11% YoY to INR 3,900 crore, and EBITDA grew 11% YoY to INR 841.4 crore with EBITDA margin flat at 21.6%.
Standalone volume grew 8% with sales up 10%. Indonesia sales rose 3%, while Africa, the US and West Asia delivered 20% growth.
Management guided FY27 EBITDA margins in the 24-26% band, according to brokerage commentary.
A board meeting was scheduled for May 6, 2026 to review audited financial results for the quarter and financial year ended March 31, 2026.

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker